COVID-19 Immunization Coverage Among People With Sickle Cell Disease

Hannah K Peng; Kevin J Dombkowski; Melissa A Plegue; Krista Latta; Ryan Malosh; Melissa S Creary; Sarah L Reeves

doi:10.1001/jamanetworkopen.2023.51618

COVID-19 Immunization Coverage Among People With Sickle Cell Disease

JAMA Netw Open. 2024 Jan 2;7(1):e2351618. doi: 10.1001/jamanetworkopen.2023.51618.

Authors

Hannah K Peng¹, Kevin J Dombkowski¹, Melissa A Plegue¹, Krista Latta¹, Ryan Malosh², Melissa S Creary³, Sarah L Reeves¹

Affiliations

¹ Susan B. Meister Child Health Evaluation and Research (CHEAR) Center, University of Michigan, Ann Arbor.
² Michigan Department of Health and Human Services, Lansing.
³ School of Public Health, University of Michigan, Ann Arbor.

No abstract available

Plain language summary

This cross-sectional study compares the completion of the primary COVID-19 vaccine series in Michigan residents with vs without sickle cell disease and by age group.

Publication types

Research Support, U.S. Gov't, P.H.S.

MeSH terms

Anemia, Sickle Cell*
COVID-19* / prevention & control
Humans
Vaccination Coverage